Презентация на тему "Thyroid disease and cancer"

Презентация: Thyroid disease and cancer
1 из 69
Ваша оценка презентации
Оцените презентацию по шкале от 1 до 5 баллов
  • 1
  • 2
  • 3
  • 4
  • 5
0.0
0 оценок

Комментарии

Нет комментариев для данной презентации

Помогите другим пользователям — будьте первым, кто поделится своим мнением об этой презентации.


Добавить свой комментарий

Аннотация к презентации

Скачать презентацию (2.56 Мб). Тема: "Thyroid disease and cancer". Содержит 69 слайдов. Посмотреть онлайн. Загружена пользователем в 2019 году. Оценить. Быстрый поиск похожих материалов.

  • Формат
    pptx (powerpoint)
  • Количество слайдов
    69
  • Слова
    другое
  • Конспект
    Отсутствует

Содержание

  • Презентация: Thyroid disease and cancer
    Слайд 1

    Thyroid Disease and Cancer

    Amy E. Baker, PA-C Clinical Medicine

  • Слайд 2

    Review: Thyroid

    Gland comprised of two lobes spanning the trachea Produces thyroxine (T4) and triiodothyronine (T3) T4 is produced only in the thyroid 20-25% of T3 is secreted by the thyroid, the rest is formed by deiodination of T4

  • Слайд 3

    Role of Thyroid Hormones

    Stimulate neural and skeletal development during fetal life Stimulate oxygen consumption at rest and bone turnover Increase GI motility Increase heart rate and contractility Maintain basal body temperature Increase production of RBC’s Control respiratory drive Increase metabolism

  • Слайд 4

    Thyroid Hormone Secretion

  • Слайд 5

    Regulated by a feedback system involving the hypothalamus, pituitary gland, and thyroid gland TRH (thyrotropin-releasing hormone) is secreted by the hypothalamus This stimulates the synthesis and release of TSH from the anterior pituitary

  • Слайд 6

    TSH stimulates the thyroid gland to produce T3 and T4 T3 and T4 directly inhibit the pituitary TSH secretion Negative feedback will increase free thyroid hormones that cause a decrease in TSH secretion and vice versa Becomes very useful in evaluating signs and symptoms of thyroid disease

  • Слайд 7

    Hypothyroidism aka Myxedema

    Deficiency of thyroid hormone secretion causing a generalized slowing of metabolism Primary disease of the thyroid, secondary disease of lack of pituitary TSH, or tertiary disease resulting in failure of hypothalamus to secrete TRH

  • Слайд 8

    Hypothyroidism

    Most common cause- Hashimoto’s Thyroiditis (aka Chronic Lymphocytic Thyroiditis) Also caused by iodine deficiency, thyroid ablation, radiation, medications, adenomas, pituitary destruction, sarcoidosis Amiodarone (due to high concentration of iodine in the drug) Hepatitis C patients (due to administration of interferon during treatment)

  • Слайд 9

    Hypothyroidism: Signs and Symptoms

    Early S/S Lethargy Weakness Cold intolerance Constipation Dry Skin Menorrhagia Depression Mild weight gain Late S/S Slowed speech Lack of sweating Peripheral edema Hoarseness Decreased sense of taste and smell Increased weight gain

  • Слайд 10

    Hypothyroidism: Physical Exam Findings

    Early PE Thin brittle nails Thinning of hair Pallor Delayed deep tendon reflexes Bradycardia Late PE Goiter Puffiness of face and eyelids Carotenemic skin color Hard pitting edema Pleural, peritoneal, and pericardial effusions

  • Слайд 11

    Goiter

    Diffuse enlargement of the thyroid Associated with hypothyroidism caused by Hashimoto’s, iodine deficiency, genetic thyroid enzyme defects, or drugs Hypothyroid phase that occurs in subacute viral thyroiditis

  • Слайд 12

    Hashimoto’s Thyroiditis

    Presents with enlarged tender thyroid gland Positive thyroid antibodies Increased TSH Can resolve on its own, but mostly treated with synthetic thyroxine

  • Слайд 13

    Hypothyroidism: Differential Diagnosis

    Any other condition causing unexplained menstrual abnormalities, myalgias, constipation, weight changes, hyperlipidemia, or anemia Myxedema added into DDX of unexplained CHF without relief from traditional medical therapy Unexplained ascites Depression and psychosis Pituitary adenomas

  • Слайд 14

    Primary Hypothyroidism: Labs

    Increased TSH (normal 0.4-5.5) Overt: TSH increased, free T4 low: treat Subclinical: TSH increased: free T4 normal: subclinical, treat if symptomatic or TSH over 10, controversial Antibody titers of thyroperoxidase and thyroglobulin increased in Hashimoto’s May also see increased cholesterol Nonspecific findings such as increased LFT’s, anemia, hyponatremia, hypoglycemia, increased creatinekinase

  • Слайд 15

    Hypothyroidism: Treatment

    Treatment of choice is levothyroxine Dosing is typically calculated at 1.6mcg/kg/day Starting doses vary depending on age, pregnancy, and other comorbidities, usually start with 50-100 mcg Start low, go slow with elderly (25 mcg) Early treatment has a very good outcome Overt: TSH increased, free T4 low: treat Subclinical: TSH increased: free T4 normal: subclinical, treat if symptomatic or TSH over 10, controversial Patients taking same daily dose demonstrate a significant increase in serum T4 levels within 1-2 weeks and near peak in 3-4 weeks

  • Слайд 16

    Monitor labs after 1 month, then 3 months, then every 6 months to evaluate efficacy of maintenance dose and need for dose adjustment Relapse can occur if treatment is interrupted Maintenance dose varies between 75-250mcg

  • Слайд 17

    Hypothyroidism: Complications

    Mostly cardiac in nature secondary to overzealous thyroid replacement Increased susceptibility to infection Psychosis Miscarriage in pregnancy TSH secreting tumors Myxedema Coma

  • Слайд 18

    Myxedema Coma

    Associated with severe hypothyroidism Induced by underlying infection (cardiac, pulmonary, or CNS), cold exposure, or drug use Caused by interstitial accumulation of mucopolysaccharides and inappropriate secretion of ADH leading to lymphedema Hyponatremia results from impaired renal tubular sodium reabsorption

  • Слайд 19

    Sx- hypothermia, hypoventilation, hyponatremia, hypoxia, hypercapnia, hypotension, convulsions, and CNS signs Mostly seen in elderly women High mortality rate, medical emergency

  • Слайд 20

    Myxedema Coma: Treatment

    Levothyroxine sodium 400 mcg IV as loading dose, then 100 mcg IV daily Treat hypothermia with warming blankets Treat hypercapnia with intubation and ventilation Treat any underlying infection Assess for and treat patients with adrenal insufficiency with hydrocortisone

  • Слайд 21

    Hypothyroidism and Pregnancy

    Critical to treat mother early on as fetus depends on T4 from mother for CNS development Maternal hypothyroidism in 1st Trimester has shown to cause some developmental delays Follow mother with TSH levels every 4-6 weeks Tight control with narrower window in pregnancy

  • Слайд 22

    Dosing of levothyroxine is variable Women who are already hypothyroid before pregnancy typically need a dose increase of 30% once pregnancy is confirmed Typically return to their original dose post-partum

  • Слайд 23

    Congenital Hypothyroidism: Cretinism

    Common cause of preventable mental retardation Affects 1:5000 infants Evident in 1st several months Can be due to congenital lack of thyroid or abnormal biosynthesis TH is essential for normal brain development and growth Neonatal screenings have been implemented to detect early If treated properly, risk of mental retardation in nonexistent Treatment of choice: levothyroxine lifelong

  • Слайд 24

    Cretinism

    Parents will report: Feeding problems Somnolence Jaundice Flaccidity Constipation Developmental delays Child will present with: Broad flat nose Protruding tongue Protruding abdomen Development of goiter Umbilical hernia Delayed growth, short stature Developmental delays

  • Слайд 25

    Children with cretinism

  • Слайд 26

    Hyperthyroidism

  • Слайд 27

    Hyperthyroidism aka Thyrotoxicosis

    Involves an increase of thyroid hormone Increased rate of metabolism Most common cause is Grave’s Disease Autoimmune Gland is usually enlarged Mostly women (8:1 ratio to men) Onset between 20-40 years of age Familial tendency

  • Слайд 28

    Hyperthyroidism

    Commonly associated with DM, myasthenia gravis, and pernicious anemia Grave’s patients are at an increased risk of developing Addison’s disease, alopecia areata, celiac disease, DM I, myasthenia gravis, cardiomyopathy, and hypokalemic periodic paralysis

  • Слайд 29

    Hyperthyroidism Grave’s disease

    Accompanied by infiltrative ophthalmopathy (exophthalmus) and pretibial myxedema Grave’s demonstrates positive antibodies on thyroid panel

  • Слайд 30

    Other Causes of Hyperthyroidism

    Most common cause-Grave’s Disease Toxic adenomas Subacute thyroiditis Thyrotoxicosis factitia Medications, especially amiodarone Also pituitary tumor, pregnancy, thyroid cancer

  • Слайд 31

    Hyperthyroidism: Signs and Symptoms

    Symptoms Nervousness Restlessness Heat intolerance Muscle cramps Frequent bowel movements Weight changes (mostly loss) Palpitations Angina Menstrual irregularities Physical Exam Findings Stare Lid lag Fine resting tremor Moist warm skin Hyperreflexia Fine hair A-fib Ophthalmopathy

  • Слайд 32

    Hyperthyroidism: Differential Diagnosis

    Anxiety or mania Anemia, leukemia, polycythemia Pheochromocytoma Acromegaly True cardiac arrythmias Myasthenia gravis

  • Слайд 33

    Primary Hyperthyroidism: Labs

    Decreased TSH, usually less than 0.1 Increased T3, T4, thyroid resin uptake, Free T4 Increased RAI uptake in Grave’s

  • Слайд 34

    Hyperthyroidism: Treatment

    Often treated by endocrinology upon initial diagnosis Varies according to age and severity Propanolol Symptomatic relief of tremor, tachycardia, diaphoresis, and anxiety Used until hyperthyroidism definitively treated Also treatment of choice for thyroid storm

  • Слайд 35

    Thiourea Drugs Methimazole or Propylthiouracil (PTU) Used for young adults or patients with mild hyperthyroidism, small goiters, or those who do not want isotope therapy Can be administered long term Lower occurrence of post-treatment hypothyroid than with surgery or RAI PTU is drug of choice during lactation and pregnancy

  • Слайд 36

    Iodinated contrast agents Effective for temporary relief Iopanoic acid or ipodate sodium Effective with severely symptomatic patients

  • Слайд 37

    Radioactive Iodine Excellent method of destroying overactive thyroid tissue by damaging the cells that concentrate it No increased risk of malignancy following treatment Contraindicated during pregnancy Usually given with propanolol Higher failure rate if given to Grave’s patients also on methimazole or PTU

  • Слайд 38

    Radioactive Iodine complications Exophthalmus/Grave’s ophthalmopathy can worsen afterwards in 15% of patients (incidence is higher in smokers) Lifelong follow-up with labs Higher incidence of rebound hypothyroidism

  • Слайд 39

    Thyroid Surgery Surgical removal of all or part of gland Good option for women who are pregnant or have small children Risk of hypoparathyroidism and laryngeal nerve palsy

  • Слайд 40

    Hyperthyroidism: Complications

    Grave’s Ophthalmopathy Subacute Thyroiditis Cardiac Complications A-fib Sinus tach Heart failure

  • Слайд 41

    Thyroid Crisis or Storm Occurs with stressful illness, thyroid surgery, or RAI administration S/S: marked delerium, severe tachycardia, n/v/d, dehydration, very high fever Very high mortality rate Propanolol is the drug of choice

  • Слайд 42

    Pretibial myxedema Thyrotoxic hypokalemia Periodic paralysis Suspect in Asian/Native American men with sudden symmetric flaccid paralysis, hypokalemia, and hypophosphatemia

  • Слайд 43

    Hyperthyroidism and Pregnancy

    Very rare Diagnosis may be delayed because many s/s are similar to what is considered “normal pregnancy” Increased risk of thyroid storm Fetal retardation of growth Premature delivery

  • Слайд 44

    Subclinical Hyperthyroidism

    Asymptomatic individuals with decreased TSH and normal T3 and Free T4 Usually does not progress to overt thyrotoxicosis Can be at increased risk of bone loss Chance of developing complications is low

  • Слайд 45

    Prognosis of Hyperthyroidism

    Rarely subsides spontaneously Variety of options for treatment Complications can persist after treatment Recurrence even after treatment is common Post-treatment hypothyroidism is common Women are at an increased risk of death from thyroid disease

  • Слайд 46

    Thyroid Nodules and Multinodular Goiter

  • Слайд 47

    General Information

    Diffuse or nodular palpable enlargement 4% of North American adults Incidence greater in iodine deficient areas Most patients are euthyroid, but still have an increased incidence of hyper/hypothyroidism Most nodules are benign (70%)

  • Слайд 48

    Diffuse Multinodular Goiter

    Usually benign Causes Benign multinodular goiter Iodine deficiency Pregnancy Grave’s disease Hashimoto’s thyroiditis Subacute thyroiditis Infection

  • Слайд 49

    Solitary Thyroid Nodule

    Mostly benign adenoma Colloid nodule Cysts Sometimes primary thyroid malignancy or metastatic neoplasm

  • Слайд 50

    Incidence of malignancy increases in patients with a history of head/neck radiation, family history of thyroid cancer, or history of other malignancies Increased risk of malignancy in nodules that are large, adherent to the trachea or strap muscles, or those associated with lymphadenopathy

  • Слайд 51

    Nodules or goiter can be large enough to be cosmetically embarrassing, cause discomfort, hoarseness, or dysphagia Retrosternal large multinodular goiters can cause dyspnea or SVC syndrome

  • Слайд 52

    Evaluation and Treatment of Nodules

    Ultrasound first- can also aid with biopsy or aspiration Biopsy indicated if nodules are growing as being monitored, appear malignant, or if over 1 cm Follow-up ultrasound in 3 months to 1 year if findings are non-invasive for stability

  • Слайд 53

    Radioactive Iodine (RAI) uptake scan-radioactive iodine (I131 or I123 injection to evaluated hot (hyperfunctioning) vs. cold (hypofunctioning) has limited use Oncology referral and radiation if indicated Toxic Solitary Nodules treated with surgery or RAI Toxic Multinodular Goiter treated with propanolol, RAI more so than surgery, and methimazole

  • Слайд 54

    Thyroid Cancer

  • Слайд 55

    Female:Male ratio 3:1 26,000 people in U.S. are diagnosed with thyroid cancer yearly and 1/250 people eventually receive this diagnosis About 13% of people at time of autopsy are found to have thyroid cancer

  • Слайд 56

    Types of Thyroid Cancer

    Papillary Follicular Medullary Anaplastic

  • Слайд 57

    Thyroid Cancer: Papillary

    Most common, least aggressive 81% of all thyroid cancers Usually presents as a single thyroid nodule Caused by genetic mutations or translocations Radiation exposure can cause it to be more aggressive

  • Слайд 58

    Tumor spreads via lymphatics becoming multifocal in 60% of patients, and involving both lobes in 30% 80% have microscopic mets in cervical lymph nodes Even with palpable mets, mortality rate does not increase, but risk of local occurrence increases Chronic low grade papillary cancer can sometimes undergo late anaplastic transformation into aggressive cancer

  • Слайд 59

    Thyroid Cancer: Follicular

    Results from gene mutations or translocations 14% of all thyroid cancers, more aggressive than papillary Some secrete enough T4 to cause thyrotoxicosis if tumor load becomes significant

  • Слайд 60

    Mets- neck, bone, lung Most absorb iodine to make diagnostic imaging possible Poorly differentiated and oncocytic cell variants are associated with high risk of mets and recurrence

  • Слайд 61

    Thyroid Cancer: Medullary

    Caused by germline mutations 3% of all thyroid cancers (1/3 familial, 1/3 sporadic, 1/3 MEN Type 2) Genetic analysis needed for diagnosis Arises from parafollicular thyroid cells that can secrete calcitonin, prostaglandins, serotonin, ACTH, and other peptides Can cause symptoms and be used as tumor markers

  • Слайд 62

    Early mets usually present adjacent to muscle and trachea and mediastinal lymph nodes Late mets to bone, lung, adrenals, liver Does not concentrate iodine Symptoms are flushing and diarrhea

  • Слайд 63

    Thyroid Cancer: Anaplastic

    Least common, most aggressive Caused by gene mutations 2% of thyroid cancers Older patients present as a rapidly enlarging goiter or mass Mets early to surrounding nodes and distant sites Local pressure symptoms of dysphagia, hoarseness, vocal cord paralysis Does not concentrate iodine

  • Слайд 64

    Other Thyroid Malignancies

    3% of all thyroid cancers Lymphomas Older women Rapidly forming enlarged painful mass arising out of multinodular goiter and affected by autoimmune thyroiditis Mostly B-cell or MALT Metastatic cancer from bronchogenic, breast, or renal cancers, or malignant melanoma

  • Слайд 65

    Thyroid Cancer: Labs and Studies

    Labs usually normal with the exception of hormone secreting tumors RAI entire body scan- used after thyroidectomy for surveillance and to look for mets U/S-evaluate nodule or goiter/aid in guidance for biopsy CT/MRI-search for mets PET Scan-search for bone mets

  • Слайд 66

    Thyroid Cancer: Treatment

    Surgery (treatment of choice) Need for thyroid hormone replacement for life s/p surgery Monitor TSH Thyroid cancer is resistant to chemo RAI therapy Radiation

  • Слайд 67

    Thyroid Cancer: Prognosis

    Papillary Very good especially in adults

  • Слайд 68

    Medullary 10 year survival rate 90% confined to thyroid 70% in cervical nodes 20% in distant mets Women

  • Слайд 69

    Questions?

Посмотреть все слайды

Сообщить об ошибке